Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-11-12 Purchase |
2024-11-14 5:21 pm |
Avalo Therapeutics Inc. | AVTX | Almenoff June Sherie Director |
1,000 | $12.75 | $12,750 | 1,000 (Indirect) |
View |
| 2023-06-26 Sale |
2023-06-28 6:12 pm |
Avalo Therapeutics Inc. | AVTX | ARMISTICE CAPITAL LLC Armistice Capital Master Fund Ltd. Boyd Steven 10% Owner |
3,683,542 | $0.58881 | $2,168,897 | 765,828 (Indirect Direct) |
View |
| 2023-06-26 Purchase |
2023-06-27 4:10 pm |
Avalo Therapeutics Inc. | AVTX | Caissa Capital Management ltd. 10% Owner |
1,608,000 | $0.64066 | $1,030,179 | 0 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-28 Exercise |
2025-04-01 8:06 pm |
N/A N/A |
Avalo Therapeutics Inc. | AVTX | Chan Mitchell Director |
3,167 | $0 | 9,500 (Direct) |
View |
| 2025-03-28 Exercise |
2025-04-01 4:55 pm |
N/A N/A |
Avalo Therapeutics Inc. | AVTX | Goldman Jonathan Director |
3,167 | $0 | 9,500 (Direct) |
View |
| 2025-03-28 Exercise |
2025-04-01 4:44 pm |
N/A N/A |
Avalo Therapeutics Inc. | AVTX | Truex Samantha Director |
3,167 | $0 | 9,500 (Direct) |
View |
| 2025-03-28 Exercise |
2025-04-01 4:37 pm |
N/A N/A |
Avalo Therapeutics Inc. | AVTX | KANTOFF AARON Director |
3,167 | $0 | 9,500 (Direct) |
View |
| 2025-03-28 Exercise |
2025-04-01 4:30 pm |
N/A N/A |
Avalo Therapeutics Inc. | AVTX | KAPLAN GILLA Director |
3,167 | $0 | 9,500 (Direct) |
View |
| 2025-03-28 Exercise |
2025-04-01 4:22 pm |
N/A N/A |
Avalo Therapeutics Inc. | AVTX | Almenoff June Sherie Director |
3,167 | $0 | 10,500 (Direct) |
View |
| 2025-03-28 Exercise |
2025-04-01 4:11 pm |
N/A N/A |
Avalo Therapeutics Inc. | AVTX | Sullivan Christopher Ryan Chief Financial Officer |
24,200 | $0 | 65,321 (Direct) |
View |
| 2025-03-28 Tax Withholding |
2025-04-01 4:11 pm |
N/A N/A |
Avalo Therapeutics Inc. | AVTX | Sullivan Christopher Ryan Chief Financial Officer |
7,285 | $8.46 | 65,321 (Direct) |
View |
| 2025-03-28 Exercise |
2025-04-01 4:01 pm |
N/A N/A |
Avalo Therapeutics Inc. | AVTX | NEIL GARRY ARTHUR Chief Executive Officer |
64,867 | $0 | 176,873 (Direct) |
View |
| 2025-03-28 Tax Withholding |
2025-04-01 4:01 pm |
N/A N/A |
Avalo Therapeutics Inc. | AVTX | NEIL GARRY ARTHUR Chief Executive Officer |
17,787 | $8.46 | 176,873 (Direct) |
View |
| 2025-03-25 Option Award |
2025-03-26 4:07 pm |
N/A 2035-03-25 |
Avalo Therapeutics Inc. | AVTX | Heffernan Michael Thomas Director |
50,000 | $0 | 50,000 (Direct) |
View |
| 2025-01-28 Option Award |
2025-01-30 5:51 pm |
N/A 2035-01-28 |
Avalo Therapeutics Inc. | AVTX | VARKI PAUL Chief Legal Officer |
100,000 | $0 | 100,000 (Direct) |
View |
| 2025-01-28 Option Award |
2025-01-30 5:43 pm |
N/A 2035-01-28 |
Avalo Therapeutics Inc. | AVTX | Sullivan Christopher Ryan Chief Financial Officer |
163,000 | $0 | 163,000 (Direct) |
View |
| 2025-01-28 Option Award |
2025-01-30 5:31 pm |
N/A 2035-01-28 |
Avalo Therapeutics Inc. | AVTX | NEIL GARRY ARTHUR CEO and Chairman of the Board |
411,000 | $0 | 411,000 (Direct) |
View |
| 2025-01-28 Option Award |
2025-01-30 5:20 pm |
N/A 2035-01-28 |
Avalo Therapeutics Inc. | AVTX | Doyle Mittie Chief Medical Officer |
155,000 | $0 | 155,000 (Direct) |
View |
| 2025-01-01 Option Award |
2025-01-03 4:06 pm |
N/A 2035-01-01 |
Avalo Therapeutics Inc. | AVTX | Riley Jennifer Chief Strategy Officer |
150,000 | $0 | 150,000 (Direct) |
View |
| 2024-08-13 Option Award |
2024-08-14 5:04 pm |
N/A 2034-08-13 |
Avalo Therapeutics Inc. | AVTX | Goldman Jonathan Director |
34,100 | $0 | 34,100 (Direct) |
View |
| 2024-08-13 Option Award |
2024-08-14 4:56 pm |
N/A 2034-08-13 |
Avalo Therapeutics Inc. | AVTX | Chan Mitchell Director |
34,100 | $0 | 34,100 (Direct) |
View |
| 2024-08-13 Option Award |
2024-08-14 4:47 pm |
N/A 2034-08-13 |
Avalo Therapeutics Inc. | AVTX | Almenoff June Sherie Director |
34,100 | $0 | 34,100 (Direct) |
View |
| 2024-08-13 Option Award |
2024-08-14 4:36 pm |
N/A 2034-08-13 |
Avalo Therapeutics Inc. | AVTX | KANTOFF AARON Director |
34,100 | $0 | 34,100 (Direct) |
View |
| 2024-08-13 Option Award |
2024-08-14 4:27 pm |
N/A 2034-08-13 |
Avalo Therapeutics Inc. | AVTX | Truex Samantha Director |
34,100 | $0 | 34,100 (Direct) |
View |
| 2024-08-13 Option Award |
2024-08-14 4:19 pm |
N/A 2034-08-13 |
Avalo Therapeutics Inc. | AVTX | KAPLAN GILLA Director |
34,100 | $0 | 34,100 (Direct) |
View |
| 2024-08-13 Option Award |
2024-08-14 4:11 pm |
N/A 2034-08-13 |
Avalo Therapeutics Inc. | AVTX | Sullivan Christopher Ryan Chief Financial Officer |
259,300 | $0 | 259,306 (Direct) |
View |
| 2024-08-13 Option Award |
2024-08-14 4:00 pm |
N/A 2034-08-13 |
Avalo Therapeutics Inc. | AVTX | NEIL GARRY ARTHUR CEO and Chairman of the Board |
695,000 | $0 | 695,060 (Direct) |
View |
| 2024-07-15 Option Award |
2024-07-16 4:23 pm |
N/A 2034-07-15 |
Avalo Therapeutics Inc. | AVTX | Doyle Mittie Chief Medical Officer |
234,000 | $0 | 234,000 (Direct) |
View |
| 2024-06-24 Option Award |
2024-06-25 4:08 pm |
N/A 2034-06-24 |
Avalo Therapeutics Inc. | AVTX | VARKI PAUL Chief Legal Officer |
150,000 | $0 | 150,000 (Direct) |
View |
| 2023-12-20 Option Award |
2023-12-21 4:05 pm |
2024-12-20 2033-12-20 |
Avalo Therapeutics Inc. | AVTX | Persson Magnus Director |
3,334 | $0 | 3,334 (Direct) |
View |
| 2023-12-20 Option Award |
2023-12-21 4:04 pm |
2024-12-20 2033-12-20 |
Avalo Therapeutics Inc. | AVTX | Almenoff June Sherie Director |
3,334 | $0 | 3,334 (Direct) |
View |
| 2023-12-20 Option Award |
2023-12-21 4:03 pm |
2024-12-20 2033-12-20 |
Avalo Therapeutics Inc. | AVTX | KAPLAN GILLA Director |
3,334 | $0 | 3,334 (Direct) |
View |
| 2023-12-20 Option Award |
2023-12-21 4:01 pm |
2024-12-20 2033-12-20 |
Avalo Therapeutics Inc. | AVTX | Chan Mitchell Director |
3,334 | $0 | 3,334 (Direct) |
View |
| 2023-06-30 Option Award |
2023-07-05 4:07 pm |
2023-06-30 2033-06-30 |
Avalo Therapeutics Inc. | AVTX | Persson Magnus Director |
28,308 | $0 | 28,308 (Direct) |
View |
| 2023-06-30 Option Award |
2023-07-05 4:05 pm |
2023-06-30 2033-06-30 |
Avalo Therapeutics Inc. | AVTX | Almenoff June Sherie Director |
4,575 | $0 | 4,575 (Direct) |
View |